“…This complex was annotated as PCGF6-PRC1, and was shown to form stable complexes with several other well-known epigenetic factors such as RING1A/B, PCGF6, L3MBTL2 [lethal(3)malignant brain tumor-like 2], RYBP, YAF2, G9A (also known as EHMT2: euchromatic histone-lysine N-methyltransferase 2), GLP (G9a-like protein 1, also known as EHMT1), and CBX1/3 (Gao et al, 2012; Hauri et al, 2016; Kloet et al, 2016; Ogawa et al, 2002; Qin et al, 2012; Trojer et al, 2011). Interestingly, PCGF6-PRC1 also interacts with sequence-specific DNA binding proteins such as E2F6, MAX, MGA and TFDP1 (transcription factor Dp-1) (Gao et al, 2012; Hauri et al, 2016; Kloet et al, 2016; Ogawa et al, 2002; Qin et al, 2012; Trojer et al, 2011). This suggests that such DNA binding proteins could play a role in sequence specific recruitment of PCGF6-PRC1 to target loci; however, this notion has not been experimentally validated.…”